Putting mathematics and artificial intelligence at the service of health
Artificial intelligence and applied mathematics are opening up new prospects for health research. By making it possible to better exploit and analyse biological data, they can help uncover new avenues for meeting patients' needs. It is with this goal in mind that CentraleSupélec and Servier are launching a new research chair in health, dedicated to applied mathematics and artificial intelligence for therapeutic innovation.
This collaboration is built on a shared ambition: to renew current therapeutic approaches and contribute to the development of innovative solutions for more effective patient care.
A collaboration between academic research and industrial innovation
The chair brings together the scientific excellence of CentraleSupélec's MICS (Mathematics and Computer Science for Complex Systems) and CDS (Cancer Data Science) laboratories with Servier's R&D teams. This complementarity between academic research and industrial expertise will make it possible to explore new avenues in therapeutic innovation, with the ambition of going further in the field of precision medicine.
Running for five years, the chair will be supported by a team of around fifteen people, bringing together researchers from CentraleSupélec and Servier. Four PhD theses are also planned as part of this collaboration.
A new chair awarded the Institut DataIA Paris-Saclay label
Awarded the Institut DataIA Paris-Saclay label, this chair marks a new step in the development of collaborations between research, artificial intelligence and health within the Paris-Saclay ecosystem. This chair is part of a long-standing collaboration between CentraleSupélec and Servier. It strengthens the ties between the two partners and places their scientific cooperation within a long-term perspective.
Véronique Le Chevalier, professor of mathematics and modelling at CentraleSupélec and researcher at MICS and within the CDS joint research unit (UMR), holds the chair. She will coordinate and steer the collaborations established as part of this partnership.
For Paul-Henry Cournède, Director of Research at CentraleSupélec, this chair "reinforces the focus on artificial intelligence and health within the school's strategic plan. In particular, it is expected to help accelerate, through applied mathematics and AI, the development of new therapeutic solutions".
With this new chair, CentraleSupélec, Servier and the Institut DataIA Paris-Saclay reaffirm their shared commitment to bringing scientific research and innovation closer together to help shape the therapies of tomorrow.
